Recent research with mice has suggested the possibility of a new line of treatment for diabetes. The treatment involves the use of a compound called nicotinamide mononucleotide (NMN). This is a compound which is produced naturally in the body. NMN is the precursor of NAD (Nicotinamide adenine dinucleotide). NAD is an important coenzyme in the body and participates in many oxidative and reductive metabolic reactions. Two important factors which promote diabetes are ageing and the consumption of high-fat diet. When both these factors are involved, the NAD content in the body decreases.
One of the consequences of diabetes is reduced glucose tolerance. Mice which were administered NMN were able to exhibit better glucose tolerance. This happened with aged mice as well as mice which were made diabetic. Thus, the use of NMN to treat diabetes offers much promise.
No comments:
Post a Comment